Telmisartan in the hypertension treatment: from pharmacological characteristics to clinical benefits
The current study describes pharmacological features and benefits of using the angiotensin II receptor blocker telmisartan in actual clinical practice. This bifunctional agent has a number of unique pharmacokinetic features: the longest duration of action, high lipophilicity and maximum efficiency i...
Saved in:
| Main Authors: | E. V. Sayutina, L. I. Butorova, E. M. Tuaeva, M. A. Osadchuk |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2020-03-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2453 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NEW APPROACHES OF THE HYPERTENSION TREATMENT: FROM CHOOSING THE BEST DRUG TO CHOOSE THE OPTIMUM DRUGS COMBINATION
by: O. D. Ostroumova, et al.
Published: (2016-01-01) -
Adding а thiazide diuretic to combined antihypertensive therapy is clinically reasonable
by: V. I. Makolkin
Published: (2008-12-01) -
Current Trends in the Treatment of Hypertension: Focus on Improving Prognosis. The Capabilities of an Amlodipine/Telmisartan Single-Pill Combination
by: O. D. Ostroumova, et al.
Published: (2020-01-01) -
An overview of fixed-dose combinations of antihypertensive drugs in South Africa
by: Natalie Schellack, et al.
Published: (2014-07-01) -
Antihypertensive and Target-Organ Protective Properties of Telmisartan and Hydrochlorothiazide Single-Pill Combination
by: O. D. Ostroumova, et al.
Published: (2019-09-01)